These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 471237

  • 1. [Use of raubasine in long-term therapy of obliterating arteriopathies].
    Andreozzi GM, Signorelli S, Magnano V, Savoca N, Mazzerbo A, Cottini E, Sorrentino F.
    Minerva Cardioangiol; 1979; 27(1-2):61-6. PubMed ID: 471237
    [No Abstract] [Full Text] [Related]

  • 2. [Raubasine-peridural infiltration combination in therapy of obstructive arteriopathies of the lower extremities].
    Giubbolini G, Setacci C, Romei R, Federici L.
    Minerva Cardioangiol; 1980 Mar; 28(3):177-82. PubMed ID: 7383367
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Intra-arterial infusion therapy in thrombo-obliterating diseases of the lower limbs].
    Kurbangaleev SM, Savel'ev IuS.
    Vestn Khir Im I I Grek; 1974 Oct; 113(10):68-71. PubMed ID: 4432347
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Medical treatment of obliterating arteriopathies of the lower limbs with vasoactive drugs].
    Raspanti D, Cameli AM, Trapani M, Dorigo D, Mazzotta A, Negro P.
    Clin Ter; 1987 Jun 30; 121(6):479-83. PubMed ID: 2973884
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Effects of the administration of buflomedil-hydrochloride on the arterial circulation of the legs in patients with obliterative arteriopathies].
    Tallarida G, Baldoni F, Peruzzi G, Raimondi G, Grimaldi I, Visigalli G, Gristina S, Massaro M, De Martinis L, Sangiorgi M.
    Cardiologia; 1983 Aug 30; 28(8):651-60. PubMed ID: 6687209
    [No Abstract] [Full Text] [Related]

  • 10. [Acute effect of intravenous administration of raubasine on the peripheral pulse in patients with diabetic arterial diseases].
    Calcaterra V.
    Minerva Cardioangiol; 1973 Aug 30; 21(7):530-44. PubMed ID: 4756347
    [No Abstract] [Full Text] [Related]

  • 11. [Medium term treatment with suloctidil in obliterating arteriopathies of the lower limbs. Personal experience].
    Marongiu G, Dettori G, Gadeddu A, Noya G, Angius P, Biglioli P.
    Minerva Cardioangiol; 1983 Aug 30; 31(7-8):407-10. PubMed ID: 6316206
    [No Abstract] [Full Text] [Related]

  • 12. [Clinical experience with a new peripheral vasodilator agent, in which are combined raubasine, and 2 ergot alkaloids in the treatment of peripheral diabetic angiopathy].
    Martínez-López JM, Calvo-Fernández R, Garrido-Toro A, Sánchez-Cañaveral F.
    Angiologia; 1973 Aug 30; 25(4):195-8. PubMed ID: 4717702
    [No Abstract] [Full Text] [Related]

  • 13. [Role and place of prolonged intra-arterial infusion in the treatment of obliterating arterial diseases of the lower extremities].
    Belichenko IA, Kungurtsev VV, Dibirov MD.
    Khirurgiia (Mosk); 1980 Mar 30; (3):48-51. PubMed ID: 7366097
    [No Abstract] [Full Text] [Related]

  • 14. [Evaluation of the efficacy of medical treatment, especially anticoagulant treatment, in arteriopathies of the lower limbs. Apropos of 41 cases].
    Chérif T, Kallel N, Guediche M.
    Tunis Med; 1986 May 30; 64(5):475-80. PubMed ID: 3824555
    [No Abstract] [Full Text] [Related]

  • 15. [Modification of cerebrovascular diseases through the oral administration of raubasine].
    Klein K, Grübl M.
    Wien Med Wochenschr; 1974 Jun 08; 124(23):360-4. PubMed ID: 4599577
    [No Abstract] [Full Text] [Related]

  • 16. [Therapeutic effect of a combination of bufenine and beta-escine as an oral delayed-action drug in obliterating arterial diseases of the lower limbs].
    Petruzzellis V, Scardigno A, Coviello C.
    Minerva Med; 1982 Feb 11; 73(5):181-6. PubMed ID: 7038552
    [Abstract] [Full Text] [Related]

  • 17. [Treatment with mesoglycan of chronic obliterative atherosclerotic arteriopathies of the legs. Hematochemical and flowmetric changes].
    di Giovanna VN.
    Clin Ter; 1988 Jun 30; 125(6):431-4. PubMed ID: 2973949
    [No Abstract] [Full Text] [Related]

  • 18. [Short-term and long-term results of treatment of chronic arteriopathies of the lower limbs with nicergoline. Importance of intensive medical therapy].
    Quiroli A.
    Minerva Cardioangiol; 1980 Dec 30; 28(12):793-804. PubMed ID: 6111767
    [No Abstract] [Full Text] [Related]

  • 19. [Clinical treatment of peripheral arterial occlusive diseases].
    Schulte B.
    Fortschr Med; 1976 Sep 23; 94(27):1500-4. PubMed ID: 823087
    [Abstract] [Full Text] [Related]

  • 20. [Treatment of hyperdyslipidemia in chronic atherosclerotic peripheral obliterating arteriopathies of the lower limbs].
    Bagliani A, Argenteri A, La Rosa A.
    Clin Ter; 1982 Dec 31; 103(6):647-61. PubMed ID: 7160147
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.